IT must now be said. The skeptics and Sinovac naysayers have been right all along. The Chinese vaccines against Covid-19 — be they Sinovac or Sinopharm — have low effectiveness rate and can reasonably be refused by prospective vaccinees on the grounds of efficacy and safety.

Premium + Digital Edition

Ad-free access


P 80 per month
(billed annually at P 960)
  • Unlimited ad-free access to website articles
  • Limited offer: Subscribe today and get digital edition access for free (accessible with up to 3 devices)

TRY FREE FOR 14 DAYS
See details
See details